US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MyoKardia

224.91

0.0000

Volume:- -

Turnover:- -

Market Cap:11.99B

PE:-39.77

High:224.91

Open:224.91

Low:224.91

Close:224.91

52wk High:225.00

52wk Low:42.65

Shares:53.32M

Float Shares:49.33M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.6559

EPS(LYR):-6.1702

ROE:-42.70%

ROA:-23.07%

PB:14.19

PE(LYR):-36.45

Loading ...

Overview Company News Filings

Company Profile

Company Name:

MyoKardia

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.myokardia.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is Mavacamten, an orally administered allosteric modulator of cardiac myosin, which is in Phase III clinical trial for the treatment of hypertrophic cardiomyopathy (HCM). The company also develops Danicamtiv, an orally administered small molecule, which completed Phase I and Phase IIa clinical trials on patients with dilated cardiomyopathy. Its preclinical programs include MYK-224, a small molecule program for the treatment of HCM targeting hypercontractility and impaired relaxation; ACT-1 for the treatment of diastolic dysfunction; and LUS-1 for the treatment of diastolic dysfunction. Myokardia, Inc. was founded in 2012 and is headquartered in Brisbane, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MYOK/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MYOK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MYOK\",,,,,undefined,":{"symbol":"MYOK","market":"US","secType":"STK","nameCN":"MyoKardia","latestPrice":224.91,"timestamp":1605560400000,"preClose":224.91,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":49327445,"shares":53322904,"eps":-5.655857,"marketStatus":"Halted","change":0,"latestTime":"11-16 16:00:00 EST","open":224.91,"high":224.91,"low":224.91,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.655857,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1446091200000,"exchange":"NASDAQ","adjPreClose":224.91,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MYOK\",,,,,undefined,":{"symbol":"MYOK","floatShares":49327445,"roa":"-23.07%","roe":"-42.70%","lyrEps":-6.17022,"shares":53322904,"dividePrice":0,"high":224.91,"amplitude":0,"preClose":224.91,"low":224.91,"week52Low":42.65,"pbRate":"14.19","week52High":225,"institutionHeld":0,"latestPrice":224.91,"eps":-5.655857,"divideRate":0,"volume":0,"delay":0,"ttmEps":-5.655857,"open":224.91,"prevYearClose":72.885},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYOK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-11-18","symbol":"MYOK","reason":null,"defaultRemindTime":1605709800000,"announcedDate":"2020-11-12","type":"delisting","dateTimestamp":1605675600000},{"market":"US","date":"2020-11-05","symbol":"MYOK","fiscalQuarterEnding":"2020/09","expectedEps":-1.48,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1604552400000,"reportTimeType":"post","actualEps":-1.6},{"market":"US","date":"2020-08-04","symbol":"MYOK","fiscalQuarterEnding":"2020/06","expectedEps":-1.46,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1596513600000,"reportTimeType":"post","actualEps":-1.27},{"market":"US","date":"2020-05-06","symbol":"MYOK","fiscalQuarterEnding":"2020/03","expectedEps":-1.38,"name":null,"time":"","type":"earning","dateTimestamp":1588737600000,"reportTimeType":"","actualEps":-1.5},{"date":"2020-02-27","symbol":"MYOK","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/12","expectedEps":-1.41,"defaultRemindTime":1582837200000,"name":null,"time":"Post Market","dateTimestamp":1582779600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYOK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MYOK\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MYOK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MYOK","date":"2020-11-16","current":-39.765857,"percent":0.324255,"low":-122.210043,"twenty":-55.049575,"median":-29.603389,"eighty":-16.830636,"high":-7.334892,"avg":-38.75465,"sd":26.334464,"marketCap":11986988819},"quantilePoints":[],"updateTime":1770547321577},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.myokardia.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is Mavacamten, an orally administered allosteric modulator of cardiac myosin, which is in Phase III clinical trial for the treatment of hypertrophic cardiomyopathy (HCM). The company also develops Danicamtiv, an orally administered small molecule, which completed Phase I and Phase IIa clinical trials on patients with dilated cardiomyopathy. Its preclinical programs include MYK-224, a small molecule program for the treatment of HCM targeting hypercontractility and impaired relaxation; ACT-1 for the treatment of diastolic dysfunction; and LUS-1 for the treatment of diastolic dysfunction. Myokardia, Inc. was founded in 2012 and is headquartered in Brisbane, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.103054},{"month":2,"riseRate":0.6,"avgChangeRate":0.003454},{"month":3,"riseRate":0.6,"avgChangeRate":0.065598},{"month":4,"riseRate":0.6,"avgChangeRate":0.067148},{"month":5,"riseRate":0.4,"avgChangeRate":0.126323},{"month":6,"riseRate":0.8,"avgChangeRate":0.016561},{"month":7,"riseRate":0.8,"avgChangeRate":0.157301},{"month":8,"riseRate":0.8,"avgChangeRate":0.46044},{"month":9,"riseRate":0.4,"avgChangeRate":0.001685},{"month":10,"riseRate":0.4,"avgChangeRate":0.054273},{"month":11,"riseRate":0.833333,"avgChangeRate":0.108897},{"month":12,"riseRate":0.6,"avgChangeRate":0.011765}],"exchange":"NASDAQ","name":"MyoKardia","nameEN":"MyoKardia"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MYOK\",market:\"US\",,,undefined,":null}}